Published on in CHOP News
CHOP cardiologists report milestone results for Fontan survivors during American Heart Association Scientific Sessions in Philadelphia.
Published on in CHOP News
More than 60 clinicians and researchers from the Cardiac Center at CHOP presented at the AHA Conference, with five presentations nominated for awards.
Published on in CHOP News
Patients who undergo the Fontan operation as children for a complex congenital heart defect are at risk of developing progressive liver fibrosis.
Published on in CHOP News
At Cardiology 2017, an international group of more than 800 medical experts gathered at the nation’s largest pediatric cardiology conference to discuss bringing science into clinical practice to provide optimal care for fetuses, neonates, children and young adults with CHD.
Published on in CHOP News
This single-center study analyzed 20 years of experience and long-term outcomes in children who underwent the Fontan operation for single-ventricle defects at The Children’s Hospital of Philadelphia between 1992 and 2009.
Published on in CHOP News
Researchers at The Children's Hospital of Philadelphia report that sildenafil significantly improved echocardiographic measures of heart function in child and young adult survivors of single ventricle heart disease.
Published on in CHOP News
In large multicenter trial of infants with single-ventricle disease, innate patient characteristics and overall medical morbidity during the child's first year significantly affected neurodevelopmental outcomes.
Published on in CHOP News
The drug Sildenafil may help children and young adults with congenital heart disease to better tolerate exercise.